This robotic surgical systems pioneer is dealing with a few issues, but its opportunities remain promising.
The surgical robotics maker posts better-than-expected quarterly earnings as it begins rollout of cardiac procedures.
With nine new procedures cleared for the da Vinci 5 robot, Intuitive’s strategy includes working with a limited number of U.S ...
The FDA 510(k) clearances for cardiac procedures cover Intuitive's latest-generation da Vinci 5 (DV5) using non-Force ...
The Company ended the fourth quarter of 2025 with $9.03 billion in cash, cash equivalents, and investments, an increase of $0.60 billion during the quarter, primarily driven by cash generated from ...
Intuitive Surgical receives FDA clearance for the da Vinci 5 robot to be used in cardiac procedures, reports 18% procedure ...
Over 3 million procedures were performed globally on Intuitive daVinci systems last year, accounting for an 18% increase.
If you are wondering whether Intuitive Surgical's share price still makes sense at current levels, the key question is how ...
CEO Dave Rosa said a strong rollout for the da Vinci 5 surgical robot in 2025 exceeded expectations, with the system driving ...
Would you pay 71x earnings for a growth stock that's slowing down?
IM's CEO said the acquisition could secure some choice contracts for Intuitive Machines in space and defense.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results